image
Fennec Pharmaceuticals Inc. FENC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.11
-4.3 %
$ 169 M
Market Cap
-300.5
P/E
BALANCE SHEET
44.9 M ASSETS
67.31%
Growth Rates
1Year 67.31%
3Years 26.10%
5Years 26.01%
7Years 6.78%
10Years 34.20%
50.8 M LIABILITIES
32.04%
Growth Rates
1Year 32.04%
3Years 97.05%
5Years 86.19%
7Years 63.26%
10Years 39.98%
-5.51 M EQUITY
52.62%
Growth Rates
1Year 52.62%
3Years -10.50%
5Years -7.92%
7Years -2.71%
10Years -25.87%
BALANCE SHEET DECOMPOSITION
Balance Sheet Fennec Pharmaceuticals Inc.
image
Current Assets 44.1 M
Cash & Short-Term Investments 26.6 M
Receivables 12.9 M
Other Current Assets 4.61 M
Non-Current Assets 822 K
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 822 K
59.26 %28.67 %10.25 %Total Assets$44.9m
Current Liabilities 6.92 M
Accounts Payable 2.88 M
Short-Term Debt 0
Other Current Liabilities 4.04 M
Non-Current Liabilities 43.9 M
Long-Term Debt 19.3 M
Other Non-Current Liabilities 24.6 M
5.66 %7.96 %38.05 %48.33 %Total Liabilities$50.8m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Jun-2004 Jun-2003 Jun-2002 Jun-2001 Jun-2000
ASSETS
Cash & Cash Equivalents 26.6 13.3 23.8 21.1 30.3 13.7 22.8 28.3 3.9 0.9 2.3 1.7 2.3 5.3 5.9 0.7 5.3 16.2 5.7 12.0 13.7 2.2 0.2 9.4 0.1
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.2 7.1 0 5.4 0 0
Receivables 12.9 8.8 1.5 0 0 0 0 0 0 0 0 0 0 0 0 69 K 0.1 0.2 0.1 0.1 0.3 22.3 K 0.1 0.1 29.9 K
Inventory 1.1 2.2 0.6 0 0 0 0 0 0 0 0 0 0 0 0 75 K 0.1 0.2 94 K 59 K 0.2 0.3 0.3 0.000001 0
Other Current Assets 3.5 2.6 0.8 1.3 1.1 0.2 0.2 0.1 46 K 77 K 65 K 89 K 62 K 54 K 46 K 79 K 99 K 0.2 0.1 0.1 0.5 0.6 0.3 0.5 0.3
Total Current Assets 44.1 26.9 26.7 22.4 31.4 13.9 22.9 28.4 4.0 1.0 2.4 1.8 2.4 5.4 6.0 0.8 5.6 16.6 5.9 13.4 21.7 3.3 6.2 9.9 0.4
PP&E 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0.6 0.3 0.9 0.4 0.5 0.6 0.5 0.2
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0 14.2 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.8 6 K 0.2 27 K 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 19.6 21.8 0 0 0
Other Assets 0 0 0 0 1.1 0 0.2 0.1 46 K 77 K 65 K 89 K 62 K 54 K 46 K 0 0 0 0 0 0 0 0 0 0
Total Assets 44.9 26.9 26.9 22.4 31.4 14.1 22.9 28.4 4.0 1.0 2.4 1.8 2.4 5.4 6.0 0.8 6.1 17.2 16.6 28.4 41.7 25.7 6.8 10.5 0.6
LIABILITIES
Accounts Payable 2.9 3.8 2.4 0.8 1.6 1.6 1.0 0.9 0.2 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.5 0.5 2.1 1.4 1.5 1.5 1.0 0.6 0.4
Short Term Debt 0 21 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 24.6 K 24.6 K
Other Current Liabilities 4.0 3.8 2.2 0.9 0.8 0.7 0.6 0.8 0.2 0.2 1.5 3.0 7.1 5.1 10.6 0.1 1.9 1.9 (1.0) (3.9) (8.9) 483 47.5 K (0.1) 59.3 K
Total Current Liabilities 6.9 7.6 4.6 1.7 2.3 2.3 1.6 1.6 0.4 0.5 1.8 3.2 7.3 5.5 10.9 0.4 2.4 2.4 4.7 2.7 1.5 1.1 0.7 0.5 0.5
Long Term Debt 19.3 30.9 24.9 5.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 33.4 K
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.6 5.2 7.2 7.9 0 0 0
Other Liabilities 24.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 K 0.6 0.7 0.7 0.6 92.1 K 1.3 42 K 0.1 76.8 K
Total Liabilities 50.8 38.5 29.5 6.6 2.3 2.3 1.6 1.6 0.4 0.5 1.8 3.2 7.3 5.5 10.9 0.4 3.0 3.1 9.0 8.4 8.7 10.3 0.7 0.6 0.6
EQUITY
Common Stock 145.6 144.3 142.6 140.8 140.7 106.4 106.4 103.0 74.5 69.2 68.7 66.8 66.0 66.0 64.9 64.9 64.9 64.9 46.5 41.3 48.3 0 0 0 0
Retained Earnings (219.7) (219.2) (203.2) (179.5) (162.1) (144.0) (131.3) (121.4) (114.3) (111.5) (110.9) (108.7) (110.5) (105.4) (108.8) (101.0) (98.0) (84.4) (71.5) (52.4) (25.5) (16.6) (9.1) (5.4) (3.0)
Other Accumulative Comprehensive Income/Loss 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 5.8 5.8 22.2 12.9 0 0 0
Total Equity (5.5) (11.6) (2.6) 15.8 29.1 11.9 21.3 26.8 3.6 0.5 0.6 (1.5) (5.0) (0.1) (4.9) 0.4 3.1 14.1 7.6 20.1 33.0 15.3 6.1 9.8 46.7 K
Total Liabilities and Equity 44.9 26.9 26.9 22.4 31.4 14.1 22.9 28.4 4.0 1.0 2.4 1.8 2.4 5.4 6.0 0.8 6.1 17.2 16.6 28.4 41.7 25.7 6.8 10.5 0.6
SHARES OUTSTANDING
Common Shares Outstanding 27.3 26.6 26.3 26.0 23.7 19.9 18.9 15.0 12.7 10.8 9.9 9.7 8.2 8.0 7.1 3.1 3.1 2.8 1.1 0.9 0.6 0.3 0.2 0.1 0.5